FDA grants Roche priority review for haemophilia treatment

The company ' s Hemlibra has nabbed a fast-track review for people with a certain form of haemophilia from by the U.S. Food and Drug Administration.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news